DRKS00014357已完成不适用
In vitro determination of optimal dose of factor substitution treatment in haemophilia patients using thrombin generation on ST Genesia
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- Male
入选标准
- •severe haemophilia A or B and factor prophylaxis
排除标准
- •no factor prophylaxis, no informed consent
研究者
相似试验
已完成
不适用
Validation Study of the S-1 dosage formula based on renal function (SCHOLAR Study: Part 2)Patients with cancer scheduled to have S-1 monotherapyJPRN-UMIN000023880Keio University School of medicine30
尚未招募
不适用
A clinical study to determine the optimal dose of WIN-1001X by evaluating its efficacy and safety in patients with early Parkinson’s diseaseDiseases of the nervous systemKCT0004536Medihelpline188
已完成
不适用
Study to Determine the Optimal Starting Dose of FSH in a Low- Dose-Stepup RegimeWHO group II ovarian failure (first-grade amenorrhea, oligomenorrhea, or anovulatory cycle), luteal phase insufficiency, or unexplained infertilityJPRN-UMIN000015669Department of Obstetrics and Gynecology,Tokushima University Hospital50
招募中
不适用
Determination of the best dose for the electrostimulation of the paravertebral muscles in the force in individuals without chronic low back paiow back painM54.5RBR-2sv9gwniversidade Estadual do Oeste do Paraná (UNIOESTE)
进行中（未招募）
不适用
Determination of the efficacious and safe dose of ivabradine in paediatric patients with dilated cardiomyopathy and symptomatic chronic heart failure aged from 6 months to less than 18 yearsEUCTR2011-001292-39-HUInstitut de Recherches Internationales Servier90